CDD3506
CAS No. 197913-15-8
CDD3506( 1-TRITYL-1H-IMIDAZOL-4-AMINE )
Catalog No. M26554 CAS No. 197913-15-8
CDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 84 | In Stock |
|
| 10MG | 135 | In Stock |
|
| 25MG | 273 | In Stock |
|
| 50MG | 387 | In Stock |
|
| 100MG | 551 | In Stock |
|
| 200MG | 728 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDD3506
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
DescriptionCDD3506 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
In VitroCDD3506 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
-
In Vivo——
-
Synonyms1-TRITYL-1H-IMIDAZOL-4-AMINE
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorGPR109A| GPR109B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number197913-15-8
-
Formula Weight325.415
-
Molecular FormulaC22H19N3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 19 mg/mL (58.39 mM)
-
SMILESNc1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(±)-N-3-Benzylnirvan...
(±)-N-3-Benzylnirvanol is a racemic mixture of (+)-N-3-Benzylnirvanol and (-)-N-3-Benzylnirvanol. Both enantiomers are selective inhibitors of cytochrome P450, specifically inhibiting CYP2C19.
-
Alpha-Amyrin
Alpha-Amyrin is an inhibitor of trypsin and chymotrypsin with antineoplastic effects. alpha-Amyrin can be used in studies about acting as a hepatomodulatory.
-
Miltirone
Miltirone is a CYPs inhibitor, it has been characterized as a low-affinity ligand for central benzodiazepine receptors.Miltirone inhibited multidrug-resistant P-glycoprotein (P-gp)-overexpressing CEM/ADR5000 cells better than drug-sensitive CCRF-CEM wild-type cells, a phenomenon termed collateral sensitivity.
Cart
sales@molnova.com